How should I manage an adult patient with Morton's neuroma presenting with forefoot pain between the third and fourth toes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Morton's Neuroma

Begin with ultrasound-guided corticosteroid plus local anesthetic injection as first-line treatment, which provides superior pain relief and functional improvement compared to non-guided injections. 1

Initial Diagnostic Approach

Start with plain radiographs of the foot to exclude other causes of forefoot pain (stress fractures, arthritis, tarsal coalitions), though radiographs will not visualize the neuroma itself 2. Confirm the diagnosis with ultrasound imaging, which is highly accurate and can differentiate Morton's neuroma from intermetatarsal bursitis—a condition that mimics neuroma symptoms but occurs in 54% of patients with intermetatarsal pain versus only 19% having true neuromas 3. MRI can be reserved for unclear cases, as it better distinguishes between these two conditions 3.

Clinical Pearls for Diagnosis

Look for these specific features:

  • Burning or shooting pain in the third webspace (most common) extending to toes
  • Sensation of "walking on a pebble"
  • Pain that limits weight-bearing activities and footwear choices 1, 4
  • More severe pain and longer symptom duration suggests true neuroma rather than bursitis 3

Treatment Algorithm

First-Line: Ultrasound-Guided Corticosteroid Injection

Ultrasound-guided corticosteroid plus local anesthetic (UG CS+LA) is the optimal initial intervention, demonstrating:

  • 15-point greater reduction in pain on VAS compared to non-guided injections (moderate-certainty evidence) 1
  • Improved function with standardized mean difference of -0.47 (moderate-certainty evidence) 1
  • 71% higher satisfaction rate compared to non-guided technique 1
  • 90% symptom relief in clinical practice 5
  • Minimal adverse events (4.9% depigmentation or fat atrophy) 1

The ultrasound guidance matters significantly—it ensures accurate needle placement and improves outcomes compared to blind injection 1.

Alternative Infiltrative Options

If corticosteroids are contraindicated or fail:

  • Capsaicin injections: 51.8% VAS reduction 6
  • Alcohol sclerosing injections: Well-tolerated but require more research 6
  • Hyaluronic acid: Effective but needs further validation 6

Second-Line: Radiofrequency Ablation

For patients who fail conservative infiltrative treatment, radiofrequency ablation provides significant pain relief:

  • 47.6% achieve complete pain relief at final follow-up 7
  • Use temperature ≥85°C for optimal results (VAS improvement of -6.97 vs -3.94 for lower temperatures) 7
  • Use ≤3 radiofrequency cycles (better outcomes than >3 cycles) 7
  • Only 2.1% complication rate, mostly self-resolving 7
  • 16.4% report no benefit, so patient selection matters 7

Surgical Neurectomy

Reserve surgery for refractory cases after exhausting non-surgical options. The 2024 Cochrane review found low-certainty evidence comparing plantar versus dorsal incision approaches, with similar satisfaction rates but different complication profiles 1. Dorsal incision carries risks of missed nerve (2.5%), vascular injury (2.5%), and wound complications, while plantar incision risks hypertrophic scarring (11.4%) 1.

Critical Pitfalls to Avoid

  1. Don't assume all intermetatarsal pain is Morton's neuroma—intermetatarsal bursitis is actually more common (54% vs 19%) and requires different management 3

  2. Don't perform blind corticosteroid injections—ultrasound guidance significantly improves outcomes 1

  3. Don't rush to surgery—90% respond to properly performed corticosteroid injections 5

  4. Don't use ultrasound alone to differentiate neuroma from bursitis—US identified 96% as having bursitis when MRI showed only 54%, indicating US overdiagnoses bursitis 3. MRI is more reliable for this distinction.

  5. Watch for corticosteroid complications: skin atrophy (3.9%), hypopigmentation (3.9%), and plantar fat pad atrophy (2.6%) can occur 1

References

Research

Treatments for Morton's neuroma.

The Cochrane database of systematic reviews, 2024

Guideline

acr appropriateness criteria® chronic foot pain.

Journal of the American College of Radiology, 2020

Research

Infiltrative Treatment of Morton's Neuroma: A Systematic Review.

Pain management nursing : official journal of the American Society of Pain Management Nurses, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.